Rare occurrence of breast cancer developing following organ transplant

Genome-wide Association Studies (GWAS) may be future for helping determine relative risk

Neoadjuvant Single-Agent PARP Inhibitor Appears Promising in BRCA Patients

Risk Factors Identified for Recurrence after NeoAdjuvant Therapy

Borderline ER-Positive Primary Breast Cancer Gains No Significant Survival Benefit from Endocrine Therapy

A Variety of Variants

Encrypt Your DNA?

Why John West M.D. is Passionate about Starting Mammography at "40not50"

Research proves that not all DCIS patients need radiation therapy

Risk Factors Identified for Recurrence after NeoAdjuvant Therapy

Discussing Fertility with Younger Patients Facing Chemotherapy

Coming Soon:  A Blood Test to Screen for Cancer

US Geographic Dialect Quiz

CRA Risk Express: Replacement for HughesRiskApps

Guide to Pathogenic Mutations - ASK2ME.ORG

PREDICT Model: Estimate Benefit of Systemic Therapy Following Breast Cancer Surgery